Ameritas Investment Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.33M Buy
100,548
+66,302
+194% +$2.94M 0.2% 90
2021
Q2
$3.87M Sell
34,246
-79,839
-70% -$3.1M 0.19% 85
2021
Q1
$4.13M Buy
114,085
+82,168
+257% +$2.92M 0.36% 64
2020
Q4
$1.17M Buy
31,917
+11,886
+59% +$436K 0.23% 107
2020
Q3
$621K Hold
20,031
0.19% 137
2020
Q2
$621K Sell
20,031
-41,836
-68% -$1.42M 0.18% 141
2020
Q1
$1.96M Buy
61,867
+43,103
+230% +$1.47M 0.31% 54
2019
Q4
$698K Sell
18,764
-20,033
-52% -$714K 0.15% 140
2019
Q3
$1.37M Buy
38,797
+27,041
+230% +$983K 0.28% 72
2019
Q2
$483K Sell
11,756
-42,719
-78% -$1.7M 0.23% 102
2019
Q1
$2.19M Buy
+54,475
New +$2.18M 0.41% 50

Other funds holding PFE

Ameritas Investment Company's PFE Position: Q3 2021 in Review

Ameritas Investment Company increased its Pfizer (PFE) stake by 194% in Q3 2021, buying an estimated $2.94M and bringing the position to 100,548 shares worth $4.33M. The position accounts for 0.2% of the portfolio, ranked #90.

Ameritas Investment Company first reported a position in PFE in Q1 2019 and has held it in 11 quarters since. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Ameritas Investment Company held 100,548 shares of Pfizer worth $4.33M as of Q3 2021.
  • Ameritas Investment Company bought 66,302 Pfizer shares in Q3 2021, an estimated $2.94M.
  • Pfizer made up 0.2% of Ameritas Investment Company's portfolio in Q3 2021, its #90 holding.
  • Ameritas Investment Company first reported a position in Pfizer in Q1 2019 and has held it in 11 quarters since.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.